| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/20/2023 | 38.48% | Piper Sandler | $17 → $19 | Maintains | Overweight |
| 07/21/2023 | 38.48% | Piper Sandler | $17 → $19 | Maintains | Overweight |
| 07/21/2023 | 38.48% | Raymond James | $18 → $19 | Maintains | Strong Buy |
| 07/20/2023 | 31.2% | Stephens & Co. | → $18 | Reiterates | Overweight → Overweight |
| 04/21/2023 | 31.2% | Stephens & Co. | → $18 | Reiterates | → Overweight |
| 04/06/2023 | 31.2% | Raymond James | $20 → $18 | Maintains | Strong Buy |
| 04/05/2023 | 31.2% | Stephens & Co. | → $18 | Initiates Coverage On | → Overweight |
| 10/28/2022 | 45.77% | Raymond James | $18.5 → $20 | Maintains | Strong Buy |
| 07/07/2022 | 34.84% | Raymond James | $18 → $18.5 | Maintains | Strong Buy |
| 04/29/2022 | 31.2% | Raymond James | $17 → $18 | Maintains | Strong Buy |
| 03/21/2022 | 60.35% | DA Davidson | → $22 | Upgrades | Neutral → Buy |
| 01/28/2022 | 23.91% | Raymond James | $16 → $17 | Maintains | Strong Buy |
| 10/22/2021 | 16.62% | Raymond James | $15 → $16 | Maintains | Strong Buy |
| 07/23/2021 | 9.33% | Raymond James | $16 → $15 | Maintains | Strong Buy |
| 03/17/2021 | 16.62% | Raymond James | $13 → $16 | Maintains | Strong Buy |
| 01/29/2021 | -5.25% | Raymond James | $12 → $13 | Maintains | Strong Buy |
| 10/23/2020 | -12.54% | Raymond James | $10 → $12 | Maintains | Strong Buy |
| 09/29/2020 | -27.11% | Piper Sandler | $11 → $10 | Maintains | Overweight |
| 09/23/2020 | -27.11% | Raymond James | → $10 | Upgrades | Outperform → Strong Buy |
| 07/24/2020 | -19.83% | Piper Sandler | $10 → $11 | Maintains | Overweight |
| 07/24/2020 | -27.11% | Raymond James | $9 → $10 | Maintains | Outperform |
| 04/24/2020 | -34.4% | Piper Sandler | $11 → $9 | Maintains | Overweight |
| 01/24/2020 | 2.04% | Raymond James | $13.5 → $14 | Maintains | Outperform |
| 12/19/2019 | 9.33% | Piper Sandler | → $15 | Initiates Coverage On | → Overweight |
| 04/09/2019 | 9.33% | Raymond James | → $15 | Initiates Coverage On | → Outperform |
What is the target price for Old Second Bancorp (OSBC)?
The latest price target for Old Second Bancorp (NASDAQ: OSBC) was reported by Piper Sandler on October 20, 2023. The analyst firm set a price target for $19.00 expecting OSBC to rise to within 12 months (a possible 38.48% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Old Second Bancorp (OSBC)?
The latest analyst rating for Old Second Bancorp (NASDAQ: OSBC) was provided by Piper Sandler, and Old Second Bancorp maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Old Second Bancorp (OSBC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Old Second Bancorp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Old Second Bancorp was filed on October 20, 2023 so you should expect the next rating to be made available sometime around October 20, 2024.
Is the Analyst Rating Old Second Bancorp (OSBC) correct?
While ratings are subjective and will change, the latest Old Second Bancorp (OSBC) rating was a maintained with a price target of $17.00 to $19.00. The current price Old Second Bancorp (OSBC) is trading at is $13.72, which is out of the analyst's predicted range.